Tesla is building the world's most advanced manufacturing platform and consensus still treats it like a car company

I'm doubling down on my TSLA conviction here at $392 because the market fundamentally misunderstands what's happening with the Tesla-SpaceX Terafab joint venture. This isn't just about chips. This is Tesla weaponizing its manufacturing DNA across multiple $100B+ TAMs simultaneously while competitors scramble to secure basic supply chains.

The Numbers Tell the Execution Story

Q1 2026 deliveries hit 523,000 units, crushing street estimates by 31,000 vehicles. More importantly, gross automotive margins expanded 240 basis points to 22.1% despite aggressive pricing. The manufacturing learning curve is accelerating, not decelerating. Fremont is now producing Model Y at $28,400 variable cost versus $31,200 twelve months ago. Austin hit 95% utilization in March. Shanghai just crossed 1.2M annual run rate.

But here's what analysts are missing: Tesla's CapEx intensity is dropping while output scales exponentially. They spent $1.8B in Q1 versus $2.1B last year while adding 180,000 units of quarterly capacity. That's manufacturing excellence compounding.

Terafab Changes Everything

The market chatter about Tesla and SpaceX scrambling for chipmaking equipment is backwards analysis. They're not scrambling. They're executing the most ambitious vertical integration play in modern industrial history. Terafab isn't just about securing chip supply. It's about Tesla controlling the entire stack from silicon to software to final assembly.

SpaceX brings aerospace-grade precision manufacturing and materials science. Tesla brings automotive scale and cost optimization. The combination creates manufacturing capabilities that literally don't exist anywhere else on Earth. When Terafab hits full production in Q3 2027, Tesla will manufacture custom silicon for FSD, energy storage, and Optimus at costs 60% below external suppliers.

FSD Revenue Inflection Accelerating

FSD take rate hit 67% in Q1, up from 41% twelve months ago. Monthly FSD subscriptions crossed 340,000, generating $68M monthly recurring revenue. The supervised FSD rollout to Model S/X fleets is driving enterprise adoption faster than projected. Commercial trucking pilots with FSD are showing 23% fuel efficiency gains and 89% reduction in safety incidents.

This isn't about when full autonomy arrives. It's about Tesla monetizing incremental autonomy improvements across 5.2M vehicles globally. Every software push generates immediate revenue. Competitors don't have this optionality.

Energy Storage Explosion Underpriced

Megapack deployments hit 14.7 GWh in Q1, up 156% year-over-year. The energy storage backlog now exceeds $12B with average gross margins of 26.4%. Lathrop is scaling faster than any Tesla factory in history. They're installing 2.1 GWh monthly capacity versus 0.8 GWh six months ago.

Grid storage is becoming Tesla's highest-margin, fastest-growing segment while trading at automotive multiples. The 4680 cell production improvements are driving energy storage unit economics that legacy players cannot match. Tesla is securing 15-year utility contracts at pricing that generates 31% IRRs.

Optimus Manufacturing Readiness

Q2 will mark the first Optimus deployment outside Tesla facilities. The pilot program with three manufacturing partners starts in July. Each Optimus unit costs $43,000 to manufacture versus $180,000+ for Boston Dynamics alternatives. Tesla is leveraging automotive manufacturing scale to drive humanoid robot costs down 85% faster than projected.

The addressable market for general-purpose humanoid robots is $4T+. Tesla has the only manufacturing platform capable of reaching consumer price points. First commercial sales begin Q4 2026.

Execution Velocity vs Street Expectations

Analysts model Tesla as a mature automotive company with 12% annual growth. Reality: Tesla is accelerating across every metric that matters. Vehicle deliveries, margin expansion, energy storage deployments, FSD adoption, manufacturing efficiency, and now vertical integration through Terafab.

The April 22 earnings call will highlight Q1 operating leverage and provide Terafab production timelines. Expect guidance raises across automotive, energy, and services segments.

Bottom Line

Tesla at $392 is trading at 23x forward earnings for a company delivering 35%+ growth across multiple trillion-dollar markets. The Terafab joint venture with SpaceX creates manufacturing optionality that doesn't exist in any other public company. Consensus still models Tesla as a car company. I'm modeling Tesla as the world's most advanced manufacturing platform with automotive, energy, AI, and robotics revenue streams. The optionality gap has never been wider.